Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Phase 3 Terminated 90 enrolled National Institute of Allergy and Infectious Diseases (NIAID)

RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to test the safety and effectiveness of ribavirin, administered as an aerosol, in preventing progression of upper respiratory tract RSV infection to RSV pneumonia in bone marrow and peripheral blood transplant recipients.

Timeline

Start: 1997-11
Primary completion: —
Completion: 2003-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ribavirin	Small molecule	—	Inhaled

Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Summary

Timeline

Drugs

Indications